David G. Kalergis
2016
In 2016, David G. Kalergis earned a total compensation of $750.4K as Chief Executive Officer at Diffusion Pharmaceuticals.
Compensation breakdown
| Option Awards | $410,240 |
|---|---|
| Salary | $244,144 |
| Other | $96,000 |
| Total | $750,384 |
Kalergis received $410.2K in option awards, accounting for 55% of the total pay in 2016.
Kalergis also received $244.1K in salary and $96K in other compensation.
Rankings
In 2016, David G. Kalergis' compensation ranked 9,570th out of 14,075 executives tracked by ExecPay. In other words, Kalergis earned more than 32.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,570 out of 14,075 | 32nd |
Division Manufacturing | 3,705 out of 5,489 | 33rd |
Major group Chemicals And Allied Products | 1,289 out of 1,895 | 32nd |
Industry group Drugs | 1,025 out of 1,538 | 33rd |
Industry Pharmaceutical Preparations | 807 out of 1,176 | 31st |
Source: SEC filing on May 12, 2017.
Kalergis' colleagues
We found five more compensation records of executives who worked with David G. Kalergis at Diffusion Pharmaceuticals in 2016.
2016
Stephen Simes
Diffusion Pharmaceuticals
Chief Executive Officer
2016
Phillip Donenberg
Diffusion Pharmaceuticals
Chief Financial Officer
2016
Mark Weinberg
Diffusion Pharmaceuticals
Former Senior Vice President, Clinical Development
2016
John Gainer
Diffusion Pharmaceuticals
Chief Scientific Officer
2016
Ben Shealy
Diffusion Pharmaceuticals